MedPath

Prochlorperazine

Generic Name
Prochlorperazine
Brand Names
Compazine, Compro
Drug Type
Small Molecule
Chemical Formula
C20H24ClN3S
CAS Number
58-38-8
Unique Ingredient Identifier
YHP6YLT61T

Overview

Prochlorperazine, also known as compazine, is a piperazine phenothiazine and first-generation antipsychotic drug that is used for the treatment of severe nausea and vomiting, as well as short-term management of psychotic disorders such as generalized non-psychotic anxiety and schizophrenia. It mainly works by depressing the chemoreceptor trigger zone and blocking D2 dopamine receptors in the brain. It was shown to also block histaminergic, cholinergic and noradrenergic receptors. Prochlorperazine was first developed in the 1950s and was first approved by the FDA in 1956. Although newer antiemetic agents such as 5-HT3 antagonists are more heavily promoted, prochlorperazine is still widely used in nausea and vomiting.

Background

Prochlorperazine, also known as compazine, is a piperazine phenothiazine and first-generation antipsychotic drug that is used for the treatment of severe nausea and vomiting, as well as short-term management of psychotic disorders such as generalized non-psychotic anxiety and schizophrenia. It mainly works by depressing the chemoreceptor trigger zone and blocking D2 dopamine receptors in the brain. It was shown to also block histaminergic, cholinergic and noradrenergic receptors. Prochlorperazine was first developed in the 1950s and was first approved by the FDA in 1956. Although newer antiemetic agents such as 5-HT3 antagonists are more heavily promoted, prochlorperazine is still widely used in nausea and vomiting.

Indication

主要用于精神障碍,亦用于治疗严重的恶心、呕吐。

Associated Conditions

  • Acute Migraine
  • Schizophrenia
  • Tension Headache
  • Non-psychotic generalized anxiety
  • Severe Nausea and vomiting

FDA Approved Products

PROCHLORPERAZINE MALEATE
Manufacturer:Bionpharma Inc.
Route:ORAL
Strength:5 mg in 1 1
Approved: 2023/09/13
NDC:69452-309
PROCHLORPERAZINE MALEATE
Manufacturer:Bionpharma Inc.
Route:ORAL
Strength:10 mg in 1 1
Approved: 2023/09/13
NDC:69452-310
PROCHLORPERAZINE MALEATE
Manufacturer:GLENMARK PHARMACEUTICALS INC., USA
Route:ORAL
Strength:5 mg in 1 1
Approved: 2023/03/17
NDC:68462-889
Prochlorperazine Edisylate
Manufacturer:FOSUN PHARMA USA INC
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:5 mg in 1 mL
Approved: 2023/05/04
NDC:72266-204
PROCHLORPERAZINE MALEATE
Manufacturer:RedPharm Drug, Inc.
Route:ORAL
Strength:5 mg in 1 1
Approved: 2022/01/20
NDC:67296-0727

Singapore Approved Products

STEMETIL INJECTION 12.5 mg/ml
Manufacturer:AVENTIS PHARMA, DAGENHAM, Sanofi S.r.L.
Form:INJECTION
Strength:12.5 mg/ml
Online:Yes
Approved: 1988/05/19
Approval:SIN01382P
PROCHLOR TABLETS 5 mg
Manufacturer:BEACONS PHARMACEUTICALS PTE. LTD.
Form:TABLET
Strength:5 mg
Online:Yes
Approved: 1988/06/23
Approval:SIN02049P
PROPERAZINE TABLET 5 mg
Manufacturer:SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Form:TABLET
Strength:5 mg
Online:Yes
Approved: 1989/05/31
Approval:SIN03002P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath